Founded by a co-creator of ChatGPT, Periodic Labs aims to build artificial intelligence that can accelerate discoveries in physics, chemistry and other fields. Ekin Dogus Cubuk, left, and Liam Fedus ...

Covid vaccines may raise the risk of certain cancers, a highly contentious study has claimed. Korean researchers said they found evidence of an association between the jabs and a heightened risk of ...

NEW YORK, Sept. 25, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global tunable laser diode analyzer market is observing significant growth owing to ...

Abstract: In this paper, an analytical temperature-dependent I-V model of gallium nitride (GaN) highelectron- mobility transistors (HEMTs) is established by using the Gaussian function. Compared with ...

Television display technology has advanced significantly over the years, progressing from bulky cathode-ray tubes (CRTs) to the ultra-slim and energy-efficient screens we have today. The best TVs of ...

National and Local United Engineering Laboratory of Flat Panel Display Technology, College of Physics and Information Engineering, Fuzhou University, Fuzhou 350100, China Fujian Science & Technology ...

David Geier, the man appointed by Health and Human Services Secretary Robert F. Kennedy Jr. to lead a federal study on the causes of autism, previously treated autistic children with puberty-blocking ...

In this tutorial, we will study the behavior of a diode reverse-biased by a Dirac pulse, subsequently considering the special (and unpublished) case of a Zener diode. In this tutorial, we will study ...

Abstract: High-electron mobility transistors (HEMTs) employing AlGaN/GaN heterostructures are suitable for high-power and high-frequency applications. To meet target specifications, GaN HEMTs must be ...

When I was growing up, about 4 or 5 years old, I had an unorthodox favourite type of reading material: service manuals for my dad’s audio equipment. This got to the point that I kept asking my parents ...

Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment. Safety, tolerability and efficacy ...